Advertisement

Spine Review

Rothman Orthopaedic Institute adds 5 NY-based surgeons to new NJ location: 5 things to know | The best opportunity to show value in spine: 4 surgeons on bundled payments | Join 1,500 attendees at the Becker’s ASC 25th Annual Meeting…

Johnson & Johnson Medical Device Companies acquires German spine co.: 5 insights | Spinal biologics market to exceed $2.6B by 2022: 3 observations | The biggest topics for ASCs today from 175 expert speakers – don’t miss the Becker’s ASC…

Stryker to purchase Invuity for $190M in 2nd acquisition deal in 2 weeks: 5 things to know | Dr. Choll Kim: Biologics holds great promise for spine surgery | 175 ASC industry speakers at the Becker’s ASC 25th Annual Meeting…

Why outpatient spine surgery is here to stay: 5 points from Dr. Kern Singh | The best hospital for neurosurgery in every state, ranked by U.S. News & World Report | Don’t miss the Becker’s ASC 25th Annual Meeting –…

How K2M will fit into Stryker’s business model – will it affect long term financial targets? | The most important changes for independent spine practices to know | Physician resigns from Texas Health Resources leadership roles after disparaging comments about…

Advertisement

Amedica sells its spine business for $10M: 4 things to know | 140 spine devices receive FDA 510(k) clearance in 2018 so far | Pa. hospital lays off 25% of staff after struggling to make payroll | Orthopedics tops list…

14 spine, neurosurgeon moves in August | Ascension fires 75% of DC-based Providence Health System’s board | U of Cincinnati grows neurosurgery department: 6 notes | Spine biologics market to exceed $2.6B by 2022: 3 observations From: Becker's Spine Review…

The best hospitals for neurosurgery in every state, ranked by U.S. News & World Report | NY hospital adds neurosurgery service: 5 things to know | Indeed: 25 best hospitals to work for in 2018 | Drs. Scott Boden, Johnny…

Dr. Scott Boden becomes Emory University School of Medicine orthopedic department chair: 5 details | Stryker to buy K2M for $1.4B, a 27% premium: 5 things to know | Last OHSU heart surgeon resigns days after program suspension | How…

Stryker expands footprint in $10B spine market with $1.4B acquisition of K2M – 5 details of the deal | Dr. Choll Kim: Biologics in spine surgery holds great promise | Vanderbilt University Medical Center points to Epic rollout for 68%…

Advertisement